Albireo Stock Valuation

ALBO
 Stock
  

USD 21.59  0.16  0.75%   

What is the current enterprise value of Albireo Pharma? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Albireo Pharma, is its stock price multiplied by the total number of shares outstanding, calculating Albireo Pharma's enterprise value requires a different approach. It uses Albireo Pharma's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Tangible Asset Value is expected to rise to about 307.3 M this year, although the value of Free Cash Flow will most likely fall to (110.9 M).
Albireo Pharma shows a prevailing Real Value of $34.02 per share. The current price of the firm is $21.59. At this time, the firm appears to be undervalued. Our model approximates the value of Albireo Pharma from analyzing the firm fundamentals such as return on equity of (31.92) %, and Profit Margin of (70.79) % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor picking up undervalued instruments and discarding overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
  
Albireo Pharma Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Albireo Pharma's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

Albireo Most Recent Valuation Data

Price Book
4.55
Enterprise Value
284.8 M
Enterprise Value Ebitda
(2.31) 
Price Sales
7.92
Enterprise Value Revenue
4.96
Undervalued
Today 21.59
Please note that Albireo Pharma's price fluctuation is not too volatile at this time. Calculation of the real value of Albireo Pharma is based on 3 months time horizon. Increasing Albireo Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Albireo Pharma is useful when determining the fair value of the Albireo stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Albireo Pharma. Since Albireo Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Albireo Stock. However, Albireo Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
34.02
Real Value
38.85
Upside
Estimating the potential upside or downside of Albireo Pharma helps investors to forecast how Albireo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Albireo Pharma more accurately as focusing exclusively on Albireo Pharma's fundamentals will not take into account other important factors:
Earnings
Estimates (4)
LowProjected EPSHigh
-6.72-5.57-3.13
Details
Hype
Prediction
LowEstimated ValueHigh
17.0321.8626.69
Details
Naive
Forecast
LowNext ValueHigh
16.8621.6926.52
Details
5 Analysts
Consensus
LowTarget PriceHigh
67.0075.8084.00
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Albireo Pharma's intrinsic value based on its ongoing forecasts of Albireo Pharma's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Albireo Pharma's closest peers. When choosing an evaluation method for Albireo Pharma, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Albireo Valuation Drivers Correlation

Many accounts on the financial statements of Albireo Pharma are highly interrelated and sometimes correlated. Consequently, when conducting Albireo's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Albireo
Click cells to compare fundamentals

Albireo Valuation Trend

Knowing Albireo Pharma's actual value is paramount for traders to make sound investment determinations. Albireo Pharma's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Albireo Pharma's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Albireo Pharma's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Albireo Market Cap

Albireo Pharma is rated third in market capitalization category among related companies. Market capitalization of Biotechnology industry is presently estimated at about 271.86 Billion. Albireo Pharma adds roughly 426.25 Million in market capitalization claiming only tiny portion of stocks in Biotechnology industry.
Capitalization  Revenue  Workforce  Valuation  Total debt

Albireo Pharma Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Albireo Pharma's current stock value. Our valuation model uses many indicators to compare Albireo Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Albireo Pharma competition to find correlations between indicators driving Albireo Pharma's intrinsic value. More Info.
Albireo Pharma is rated third in price to book category among related companies. It is rated third in price to earning category among related companies . The value of Price to Earnings Ratio is estimated to slide to -13.5. The value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA is expected to slide to about (21.4 M). Comparative valuation analysis is a catch-all model that can be used if you cannot value Albireo Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Albireo Pharma's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Albireo Pharma's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Albireo Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Albireo Pharma and how it compares across the competition.

About Albireo Pharma Valuation

The stock valuation mechanism determines the current worth of Albireo Pharma on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Albireo Pharma. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Albireo Pharma based exclusively on its fundamental and basic technical indicators. By analyzing Albireo Pharma's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Albireo Pharma's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Albireo Pharma. We calculate exposure to Albireo Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Albireo Pharma's related companies.
Fiscal Year End
December
Industry
Biotechnology
Concentration
Biotechnology
Full Time Employees
130.0
Service Category
Biotechnology
Employer Id Number
90-0136863
Last ReportedProjected for 2022
Gross Profit39.2 M42.3 M
Profit Margin(75.47) (81.43) 

Albireo Pharma Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Albireo Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio4.19
Revenue Growth238.00%
Enterprise Value To Ebitda-1.78
Enterprise Value To Revenue4.41

Albireo Pharma Current Valuation Indicators

Valuation refers to the process of determining the present value of Albireo Pharma and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Albireo we look at many different elements of the entity such as Albireo's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Albireo Pharma's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Albireo Pharma's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Albireo Pharma, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Albireo Pharma's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Albireo Pharma's worth.
Please continue to Trending Equities. Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for Albireo Stock analysis

When running Albireo Pharma price analysis, check to measure Albireo Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Albireo Pharma is operating at the current time. Most of Albireo Pharma's value examination focuses on studying past and present price action to predict the probability of Albireo Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Albireo Pharma's price. Additionally, you may evaluate how the addition of Albireo Pharma to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Is Albireo Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Albireo Pharma. If investors know Albireo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Albireo Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
454.3 M
Quarterly Revenue Growth YOY
1.68
Return On Assets
(0.25) 
Return On Equity
(0.93) 
The market value of Albireo Pharma is measured differently than its book value, which is the value of Albireo that is recorded on the company's balance sheet. Investors also form their own opinion of Albireo Pharma's value that differs from its market value or its book value, called intrinsic value, which is Albireo Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Albireo Pharma's market value can be influenced by many factors that don't directly affect Albireo Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Albireo Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Albireo Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Albireo Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.